Priority candidates include genetic and epigenetic markers at established T1D loci such as INS VNTR (AIRE‐dependent regulation of thymic insulin), IL2RA (sex‐dependent enhancer activity), CTLA4 (sex‐modified checkpoint control) and CLEC16A (sex‐influenced autophagy pathways). The gene discussed is CTLA4; the disease is type 1 diabetes mellitus.